Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 50, 2013, Pages 20218-20223

  Grewal, Prabhjit K ^a,b   Aziz, Peter V ^a,b   Uchiyama, Satoshi ^c   Rubio, Gabriel R ^a,b   Lardone, Ricardo D ^a,b   Le, Dzung ^d   Varki, Nissi M ^d   Nizet, Victor ^c   Marth, Jamey D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASHWELL MORELL RECEPTOR; CELL RECEPTOR; SIALIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HOST RESISTANCE; INFECTION RESISTANCE; LIVER CELL; MOUSE; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA;

EID: 84890290183     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1313905110     Document Type: Article

References (25)

1. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG (2011) The pathogenesis of sepsis. Annu Rev Pathol 6:19-48.
2. Levi M, Schultz M, van der Poll T (2010) Sepsis and thrombosis. Semin Thromb Hemost 36:367-377.
3. Marshall JC (2001) Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 29(7, Suppl):S99-S106.
4. Giamarellos-Bourboulis EJ (2013) The failure of biologics in sepsis: Where do we stand? Int J Antimicrob Agents 42(Suppl):S45-S47.
5. Angus DC (2011) The search for effective therapy for sepsis: Back to the drawing board? JAMA 306(23):2614-2615.
6. Grewal PK, et al. (2008) The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 14(6):648-655.
7. Ashwell G, Morell AG (1974) The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol 41(0):99-128.
8. Varki A, Gagneux P (2012) Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci 1253:16-36.
9. Ohtsubo K, Marth JD (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126(5):855-867.
10. Roggentin P, Schauer R, Hoyer LL, Vimr ER (1993) The sialidase superfamily and its spread by horizontal gene transfer. Mol Microbiol 9(5):915-921.
11. Tong HH, Liu X, Chen Y, James M, Demaria T (2002) Effect of neuraminidase on receptor-mediated adherence of Streptococcus pneumoniae to chinchilla tracheal epithelium. Acta Otolaryngol 122(4):413-419.
12. King SJ, Hippe KR, Weiser JN (2006) Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae. Mol Microbiol 59(3):961-974.
13. Manco S, et al. (2006) Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect Immun 74(7):4014-4020.
14. Chang YC, Uchiyama S, Varki A, Nizet V (2012) Leukocyte inflammatory responses provoked by pneumococcal sialidase. MBio, 10.1128/mBio.00220-11.
15. Sørensen AL, et al. (2009) Role of sialic acid for platelet life span: Exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes. Blood 114(8):1645-1654.
16. Sullam PM, Payan DG, Dazin PF, Valone FH (1990) Binding of viridans group streptococci to human platelets: A quantitative analysis. Infect Immun 58(11):3802-3806.
17. Kahn F, Hurley S, Shannon O (2013) Platelets promote bacterial dissemination in a mouse model of streptococcal sepsis. Microbes Infect 15(10-11):669-676.
18. Sharon M, et al. (2012) Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade. PLoS One 7(7):e41549.
19. Marth JD (2008) A unified vision of the building blocks of life. Nat Cell Biol 10(9):1015-1016.
20. Ohtsubo K, Chen MZ, Olefsky JM, Marth JD (2011) Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat Med 17(9):1067-1075.
21. Langley RJ, et al. (2013) An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med 5(195):95ra95.
22. Wellen KE, Thompson CB (2012) A two-way street: Reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol 13(4):270-276.
23. Sriskandan S, Altmann DM (2008) The immunology of sepsis. J Pathol 214(2):211-223.
24. Wang Y, et al. (2001) Modeling human congenital disorder of glycosylation type IIa in the mouse: Conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology 11(12):1051-1070.
25. Ellies LG, et al. (2002) Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci USA 99(15):10042-10047.